PharmaSGP Holding SE reaffirmed earnings guidance for the year 2022. Given this very strong performance in the first half of the year, the Management Board confirms the guidance for the current 2022 financial year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.2 EUR | 0.00% | -0.89% | -1.33% |
Apr. 18 | PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023 | CI |
Apr. 18 | PharmaSGP Holding SE Announces Changes to Dividend Policy | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.33% | 284M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- PSG Stock
- News PharmaSGP Holding SE
- PharmaSGP Holding SE Reaffirms Earnings Guidance for the Year 2022